Found: 10
Select item for more details and to access through your institution.
A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 605, doi. 10.1007/s00262-017-1969-z
- By:
- Publication type:
- Article
Phospho-STAT1 expression as a potential biomarker for anti-PD-1/anti-PD-L1 immunotherapy for breast cancer.
- Published in:
- International Journal of Oncology, 2019, v. 54, n. 6, p. 2030, doi. 10.3892/ijo.2019.4779
- By:
- Publication type:
- Article
Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 6, p. 1390, doi. 10.1002/ijc.28780
- By:
- Publication type:
- Article
Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 3, p. 393, doi. 10.1007/s10120-023-01364-7
- By:
- Publication type:
- Article
Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer–T cell coculture models.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 3, p. 611, doi. 10.1007/s10120-020-01151-8
- By:
- Publication type:
- Article
Immune suppression caused by PD-L2 expression on tumor cells in gastric cancer.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 6, p. 961, doi. 10.1007/s10120-020-01079-z
- By:
- Publication type:
- Article
Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility.
- Published in:
- 2016
- By:
- Publication type:
- journal article
PD‐L1 expression is mainly regulated by interferon gamma associated with JAK‐STAT pathway in gastric cancer.
- Published in:
- Cancer Science, 2018, v. 109, n. 1, p. 43, doi. 10.1111/cas.13424
- By:
- Publication type:
- Article
Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment.
- Published in:
- Cancer Science, 2014, v. 105, n. 10, p. 1236, doi. 10.1111/cas.12503
- By:
- Publication type:
- Article